Bessemer funds plan sale of 242,100 Class A shares

Bessemer Venture Partners entities filed a notice to sell 242,100 Class A shares through Merrill Lynch on the NYSE, with an aggregate market value of 9,383,796 and 37,919,155 Class A shares outstanding.

Rhea-AI Filing Summary

Bessemer Venture Partners entities filed a notice to sell 242,100 Class A shares through Merrill Lynch on the NYSE, with an aggregate market value of 9,383,796 and 37,919,155 Class A shares outstanding. The approximate sale date is 02/12/2026.

The shares to be sold were acquired on 02/04/2020 in a private placement from the issuer for cash. The filing also lists recent Class A share sales over the past three months by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP, including multiple transactions in November and December 2025 with disclosed gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing for HNGE disclose?

The filing discloses a planned sale of 242,100 Class A shares through Merrill Lynch on the NYSE. It also details how the shares were originally acquired and lists recent Class A share sales over the prior three months by related Bessemer Venture Partners entities.

How many HNGE Class A shares are proposed for sale?

The notice covers a proposed sale of 242,100 Class A shares. It reports an aggregate market value of 9,383,796 for this block, with 37,919,155 Class A shares outstanding, giving investors context on the relative size of the potential sale versus total shares.

When and how were the HNGE shares being sold acquired?

The 242,100 Class A shares were acquired on 02/04/2020 in a private placement from the issuer. The filing specifies that the purchase price was paid in cash on the same date, clarifying both the acquisition method and timing for these securities.

On which exchange are the HNGE Class A shares expected to be sold?

The filing indicates that the Class A shares are expected to be sold on the NYSE. Merrill Lynch, located at One Bryant Park in New York, is listed as the broker handling the transaction, and the approximate sale date disclosed is 02/12/2026.

What recent HNGE share sales by Bessemer funds are reported?

The document lists several Class A share sales in the past three months by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP, including trades on 11/18/2025, 11/26/2025, 11/28/2025, and 12/05/2025, each with specified share amounts and gross proceeds.

What representation does the seller make about information on the issuer?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. The notice also warns that intentional misstatements or omissions of facts constitute federal criminal violations under 18 U.S.C. 1001.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:51 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001748910
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET, 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Bessemer Venture Partners X Institutional LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	242100	9383796	37919155	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	02/04/2020	Private Placement	Issuer			242100	02/04/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/18/2025	373955	14976898
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/26/2025	103160	4979533.2
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/28/2025	23176	1162403.87
Bessemer Venture Partners X LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	12/05/2025	2614	130612.63
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/18/2025	351045	14059352
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/26/2025	96840	4674466.8
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	11/28/2025	21757	1091233.21
Bessemer Venture Partners X Institutional LP 1865 Palmer Avenue, STE 104 Larchmont NY 10538	Class A	12/05/2025	2453	122568.02

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Augie Wilkinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)